Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Outside the Lab

Outside the Lab Genetics and epigenetics

From Bench to Bedside and Back Again

| Roisin McGuigan

Sitting Down With James Wilson, Rose H. Weiss Professor and Director, Orphan Disease Centre, Profession of Medicine and Pediatrics, University of Pennsylvania

Outside the Lab Clinical care

A Question of Cancers

| John Srigley

The ICCR works with pathologists and groups worldwide to develop standardized guidelines for the diagnosis and reporting of various cancer types

Outside the Lab Clinical care

Antibiotic Test Results – Done Right

| Sponsored by Beckman Coulter

An advanced system can identify pathogens and detect broad-ranging resistance, allowing pathologists to select the most appropriate drugs with accuracy and speed

Outside the Lab Digital and computational pathology

Automation Inevitable?

| Randy Van Ommeren, Kevin Faust, and Phedias Diamandis

As deep learning moves into the pathology sphere, the way we do our jobs will change – but we have yet to determine exactly how

Outside the Lab Digital and computational pathology

Intelligent Pharma Partners

| Holger Lange and Cris Luengo

How combining their efforts with those of the pharmaceutical industry can help pathologists make a business case for AI

Outside the Lab Biochemistry and molecular biology

Fighting Resistance in Bloodstream Infections

| Luke Turner

When bacteria become resistant to the last line of defense, rapid detection and treatment is more important than ever. A new assay can help with treatment selection for carbapenem-resistant infections

Outside the Lab Histology

Case of the Month

Can you diagnose this 29-year-old’s painful subungual tumor?

Outside the Lab Profession

A Community of Equals

What makes pathology and laboratory medicine unique? Everyone, from trainee to department chair, receives respect

Outside the Lab Omics

Opening Doors With Omics

Sitting Down With Oliver Fiehn, Director of NIH West Coast Metabolomics Center

Outside the Lab Clinical care

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register